CD34 and ischemia: The use of intramyocardial injection of autologous bone marrow derived mononuclear cells such as CD34+ and AC133+ stem cells has also yielded positive efficacy signals with regard to angina improvement and myocardial perfusion in patients with refractory ischemia[13,14].